510(k) vs De Novo: how do you decide?
The first thing I would do is slow down and identify the actual regulatory question. First establish intended use and risk. Search for a suitable predicate. If there is one, assess substantial equivalence. If none exists and risk is low to moderate, evaluate De Novo. Higher-risk products may require PMA
